Systemic Sclerosis
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension [Phase 1]
Phase 1 trial of dimethyl fumarate in systemic sclerosis-associated pulmonary arterial hypertension has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis [Phase 2]
Phase 2 long-term safety study for GLPG1690 in systemic sclerosis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis [Phase 3]
Phase 3 trial evaluating the efficacy of Botulinum Toxin A for Raynaud phenomenon secondary to systemic sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis [Phase 2]
Phase 2 trial assessing effectiveness and safety of SAR156597 for diffuse systemic sclerosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients [Phase 4]
Phase 4 trial evaluating acetylsalicylic acid for vascular dysfunction markers in systemic sclerosis (scleroderma) patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases [Phase 4]
Phase 4 trial update for PLACENTEX IM in patients with scleroderma, showing termination of the study.
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis [Phase 2]
Phase 2 trial evaluating the combination of bortezomib and mycophenolate in interstitial lung disease associated with systemic sclerosis (sc…
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Prednisolone in Early Diffuse Systemic Sclerosis [Phase 2]
Phase 2 clinical trial update evaluating prednisolone in early diffuse systemic sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study [NA]
Feasibility study results for the SPIN Hand Program in scleroderma patients have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases [Phase 2]
Phase 2 clinical trial evaluating low-dose IL-2 to induce regulatory T cells in various autoimmune and inflammatory diseases; trial complete…
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis [Phase 2]
Phase 2 trial evaluating safety and efficacy of oral treprostinil for calcinosis in patients with systemic sclerosis has completed with resu…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis [Phase 2]
Phase 2 proof-of-mechanism study of GSK2330811 in diffuse cutaneous systemic sclerosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis [Phase 2]
Phase 2 trial evaluating imatinib mesylate for systemic sclerosis showed results on efficacy and tolerability.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis [Phase 2]
Phase 2 clinical trial evaluating the safety and effectiveness of GLPG1690 in systemic sclerosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment [Phase 1, Phase 2]
Phase 1/2 trial update on systemic sclerosis vasculopathy reporting completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan [Phase 4]
Phase 4 trial updating exercise-induced pulmonary hypertension in systemic sclerosis and treatment with ambrisentan.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients [EARLY_Phase 1]
Early Phase 1 trial assessing autologous adipose-derived stromal vascular fraction injections for finger involvement in systemic sclerosis; …
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Cardiac Safe Transplants for Systemic Sclerosis [Phase 2, Phase 3]
Clinical trial update for a cardiac-safe transplant approach in systemic sclerosis/scleroderma completed phases 2 and 3; status terminated w…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial [Phase 3]
Phase 3 trial of autologous stem cell systemic sclerosis immune suppression has been terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-15Clinical Trial Update: Safety Of Fat Micrografts With Adipose-Derived Stromal Vascular Fraction In Hands Of Patients With Systemic Sclerosis [Phase 2]
Phase 2 clinical trial evaluating the safety of fat micrografts with adipose-derived stromal vascular fraction for hands in patients with sy…
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis [Phase 2]
Phase 2 trial evaluating local injection of Botulinum toxin Type B for digital ulcers in systemic sclerosis; study completed.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating tofacitinib for early diffuse cutaneous systemic sclerosis (dcSSc) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH) [Phase 2]
Phase 2 trial update on early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis (SSc-APAH); study c…
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study [Phase 1, Phase 2]
A phase 1/2 proof-of-concept trial evaluating treprostinil delivered via iontophoresis for systemic sclerosis-related digital ulcers has com…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating the efficacy and safety of rituximab in participants with systemic sclerosis (scleroderma) and related…